Cart
sales@molnova.com
Difubenzuron
CAS No. 35367-38-5
Difubenzuron( Diflubenzuron | DU 112307 | DU112307 | DU-112307 )
Catalog No. M18469 CAS No. 35367-38-5
Diflubenzuron is a benzoyl-urea insecticide, found to be a potent inhibitor of melanosome synthesis in mouse melanoma cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 50 | In Stock |
|
| 100MG | 188 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDifubenzuron
-
NoteResearch use only, not for human use.
-
Brief DescriptionDiflubenzuron is a benzoyl-urea insecticide, found to be a potent inhibitor of melanosome synthesis in mouse melanoma cells.
-
DescriptionDiflubenzuron is an insect growth regulator and chitin synthesis inhibitor. It inhibits growth of Tribolium, Anopheles, Ascaris and Haemonchus.
-
In Vitro——
-
In Vivo——
-
SynonymsDiflubenzuron | DU 112307 | DU112307 | DU-112307
-
PathwayEndocrinology/Hormones
-
TargetReductase
-
RecptorCYP1A1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number35367-38-5
-
Formula Weight310.68
-
Molecular FormulaC14H9ClF2N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFc1cccc(F)c1C(=O)NC(=O)Nc1ccc(Cl)cc1
-
Chemical NameN-((4-chlorophenyl)carbamoyl)-2,6-difluorobenzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Norman J O, Meola S M. Inhibition of melanogenesis in B16-F1 melanoma cells after exposure to diflubenzuron.[J]. Antimicrobial Agents & Chemotherapy, 1983, 23(2):313-6.
molnova catalog
related products
-
Turosteride
Turosteride is a small molecule steroidal 5α-reductase (5α-reductase) inhibitor.
-
BYAKANGELICIN(b)
BYAKANGELICINa main furanocoumarin constituent isolated and characterized as an aldose reductase inhibitorand is effective for the treatment of sugar cataracts and diabetic neuropathy and hence might be useful as a lead compound for the development of new type drugs for clinical use.
-
AT-007
AT-007 is an orally active CNS penetrant Aldose Reductase inhibitor for the treatment of Galactosemia (IC50: 100 pM).
